Copyright
©The Author(s) 2021.
World J Gastroenterol. Oct 28, 2021; 27(40): 6888-6907
Published online Oct 28, 2021. doi: 10.3748/wjg.v27.i40.6888
Published online Oct 28, 2021. doi: 10.3748/wjg.v27.i40.6888
Table 11 Ratio of bile acids in each experimental group to corresponding composition of negative control group
| Bile acid | Negative | Model | Positive | FGL | FGM | FGH |
| CA | 1.00 | 2.57 | 1.38 | 2.16 | 1.92 | 1.40 |
| GLCA | 1.00 | 1.61 | 1.08 | 1.45 | 1.17 | 1.15 |
| GDCA | 1.00 | 4.45 | 2.43 | 3.53 | 2.78 | 2.14 |
| GCDCA | 1.00 | 1.74 | 1.18 | 1.85 | 1.28 | 1.09 |
| GCA | 1.00 | 1.30 | 1.25 | 1.22 | 1.16 | 1.12 |
| TCA | 1.00 | 1.99 | 1.11 | 1.90 | 1.37 | 1.31 |
| CDCA | 1.00 | 4.12 | 2.08 | 3.76 | 2.90 | 2.03 |
| UDCA | 1.00 | 5.68 | 3.17 | 4.87 | 3.72 | 3.62 |
| TUDCA | 1.00 | 6.00 | 3.08 | 4.73 | 4.13 | 3.87 |
| TCDCA | 1.00 | 3.24 | 1.57 | 2.92 | 2.63 | 2.03 |
| DCA | 1.00 | 5.16 | 2.40 | 4.48 | 3.84 | 2.95 |
- Citation: Wang MF, Zhao SS, Thapa DM, Song YL, Xiang Z. Metabolomics of Fuzi-Gancao in CCl4 induced acute liver injury and its regulatory effect on bile acid profile in rats. World J Gastroenterol 2021; 27(40): 6888-6907
- URL: https://www.wjgnet.com/1007-9327/full/v27/i40/6888.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i40.6888